Dolgic Interactions
There are 608 drugs known to interact with Dolgic (acetaminophen / butalbital), along with 14 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 42 are major, 522 are moderate, and 44 are minor.
- View all 608 medications that may interact with Dolgic
- View Dolgic alcohol/food interactions (1)
- View Dolgic disease interactions (14)
Most frequently checked interactions
View interaction reports for Dolgic (acetaminophen / butalbital) and the medicines listed below.
- allopurinol
- Asacol (mesalamine)
- Ativan (lorazepam)
- Axert (almotriptan)
- Byetta (exenatide)
- calcium citrate
- Canasa (mesalamine)
- Celexa (citalopram)
- Cipro (ciprofloxacin)
- clonazepam
- Cortifoam (hydrocortisone)
- Diflucan (fluconazole)
- Flagyl (metronidazole)
- Flexeril (cyclobenzaprine)
- Frova (frovatriptan)
- Humira (adalimumab)
- lisinopril
- Meprozine (meperidine / promethazine)
- mercaptopurine
- Mircette (desogestrel / ethinyl estradiol)
- MS Contin (morphine)
- MSIR (morphine)
- Nasacort AQ (triamcinolone nasal)
- Nasonex (mometasone nasal)
- omeprazole
- Ortho Tri-Cyclen (ethinyl estradiol / norgestimate)
- Ortho Tri-Cyclen Lo (ethinyl estradiol / norgestimate)
- Patanase (olopatadine nasal)
- Phenergan (promethazine)
- Ponstel (mefenamic acid)
Dolgic alcohol/food interactions
There is 1 alcohol/food interaction with Dolgic (acetaminophen / butalbital).
Dolgic disease interactions
There are 14 disease interactions with Dolgic (acetaminophen / butalbital) which include:
- alcoholism
- liver disease
- acute alcohol intoxication
- drug dependence
- liver disease
- porphyria
- rash
- respiratory depression
- PKU
- adrenal insufficiency
- depression
- hematologic toxicity
- osteomalacia
- paradoxical reactions
More about Dolgic (acetaminophen / butalbital)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: analgesic combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.